Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism.

Ma SG, Yang LX, Bai F, Xu W, Hong B.

Eur J Intern Med. 2012 Sep;23(6):e136-40. doi: 10.1016/j.ejim.2012.04.011. Epub 2012 May 15.

PMID:
22863438
2.

Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.

Sewerynek J, Wiktorska J, Nowak D, Lewinski A.

Endocr Regul. 2000 Jun;34(2):83-9.

PMID:
10911409
3.

Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.

Braclik M, Marcisz C, Giebel S, Orzeł A.

Thyroid. 2008 May;18(5):545-50. doi: 10.1089/thy.2007.0300.

PMID:
18466078
5.

Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease.

Mugii S, Hanada H, Okubo M, Masuda D, Takeoka K, Hidaka Y, Ohama T, Matsuyama A, Nakagawa-Toyama Y, Nishida M, Ishigami M, Komuro I, Yamashita S.

J Atheroscler Thromb. 2012;19(10):890-6. Epub 2012 Jul 4.

6.

Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.

Altinova AE, Törüner FB, Aktürk M, Bukan N, Cakir N, Ayvaz G, Arslan M.

Clin Endocrinol (Oxf). 2006 Oct;65(4):530-5.

PMID:
16984248
7.

The effect of L-thyroxine replacement therapy on ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hypothyroidism.

Erem C, Suleyman AK, Civan N, Mentese A, Nuhoglu İ, Uzun A, Coskun H, Deger O.

Endocr Res. 2016 Nov;41(4):350-360. Epub 2016 Apr 25.

PMID:
27111422
8.

Ischemia-modified albumin levels in overt and subclinical hypothyroidism.

Reddy SV, Suchitra MM, Pradeep V, Alok S, Suresh V, Bitla AR, Srinivasa Rao PV.

J Endocrinol Invest. 2015 Aug;38(8):885-90. doi: 10.1007/s40618-015-0283-x. Epub 2015 Apr 11.

PMID:
25862649
9.

Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress.

Erem C, Suleyman AK, Civan N, Mentese A, Nuhoglu İ, Uzun A, Ersoz HO, Deger O.

Endocr J. 2015;62(6):493-501. doi: 10.1507/endocrj.EJ14-0542. Epub 2015 Apr 3.

10.

Serum ischemic modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism.

Ersoy K, Anaforoğlu İ, Algün E.

Endocrine. 2013 Apr;43(2):430-3. doi: 10.1007/s12020-012-9796-7. Epub 2012 Sep 23.

PMID:
23001626
11.

Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia.

Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR.

Clin Biochem. 2009 May;42(7-8):666-71. doi: 10.1016/j.clinbiochem.2009.01.010. Epub 2009 Feb 4.

PMID:
19318029
12.

The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.

Philippou G, Koutras DA, Piperingos G, Souvatzoglou A, Moulopoulos SD.

Clin Endocrinol (Oxf). 1992 Jun;36(6):573-8.

PMID:
1424182
13.

Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.

Gazdag A, Nagy EV, Burman KD, Paragh G, Jenei Z.

Exp Clin Endocrinol Diabetes. 2010 Jun;118(6):381-7. doi: 10.1055/s-0029-1224156. Epub 2009 Aug 5.

PMID:
19658059
14.
15.

Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study.

Radácsi A, Kovács G, Bernard W, Feldkamp J, Horster FA, Szabolcs I.

Endocrine. 2003 Jul;21(2):133-6. Erratum in: Endocrine. 2003 Dec;22(3):341.

PMID:
12897375
16.

Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.

Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM.

Clin Endocrinol (Oxf). 2001 Feb;54(2):197-204.

PMID:
11207634
17.

Bone remodelling markers and serum cytokines in patients with hyperthyroidism.

Akalin A, Colak O, Alatas O, Efe B.

Clin Endocrinol (Oxf). 2002 Jul;57(1):125-9.

PMID:
12100080
18.

Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.

Nishitani H, Okamura K, Noguchi S, Inoue K, Morotomi Y, Fujishima M.

Horm Metab Res. 1990 Sep;22(9):490-3.

PMID:
2258137
19.

Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.

Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P.

Acta Endocrinol (Copenh). 1983 Sep;104(1):50-6.

PMID:
6624364
20.

Effect of thyroid function on concentrations of lipoprotein(a)

Engler H, Riesen WF.

Clin Chem. 1993 Dec;39(12):2466-9.

Supplemental Content

Support Center